drugset / Trial / NCT00710554

A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia

NCT00710554

Phase 3 Completed 246 enrolled Jazz Pharmaceuticals
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to evaluate the efficacy of Sativex® compared with placebo in relieving peripheral neuropathic pain associated with allodynia.

Timeline

Start
2005-08
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabiximols Other / unclassified Other

Indications